I am a nuclear medicine physician and Director of the Targeted Radiotherapy Section in the Department of Radiology. My area of expertise is targeted radionuclide therapy, PET, and molecular imaging. I have a particular interest in developing new targeted therapeutic agents.
Prior to joining Memorial Sloan Kettering Cancer Center, I was a tenured investigator at the National Institutes of Health. The collaborative work I did there in Phase 1 and Phase 2 clinical trials has contributed to advancements in the field of radioimmunotherapy.